SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Ariella who wrote (432)1/29/1999 4:21:00 PM
From: David Israel-Rosen  Read Replies (1) | Respond to of 1386
 
Smile

Let us hope these are good. The price...I hope is not an indication...
The Very least, PARS mgt is guarding against leaks, and the stock price shows...



To: Ariella who wrote (432)1/29/1999 4:30:00 PM
From: Tony van Werkhooven  Read Replies (1) | Respond to of 1386
 
Ariella- Based on my conversation with the company, a news release would be forthcoming re. Alrex/Lot sales and a seperate news release re. filing in Europe. I was unable to extract a time frame (you indicated prior to release of earnings at the end of February). You must be more persuasive than I am <BG>.

So, we will wait for the good news.

Tony



To: Ariella who wrote (432)1/30/1999 5:11:00 PM
From: crysball  Respond to of 1386
 
Pending News Releases form PARS

One of my colleagues sent Gwen an email requesting news and Gwen replied in writing no new news releases befrore the Feb 11 announcement on year end financials.

Wish PARS IR would be consistent in what they are saying to investors........as 3 different people get different responses to apparently simimilar questions.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News